Hans-Jürgen Möller Selected Research

Hans-Jürgen Möller Research Topics

Disease

81	Schizophrenia (Dementia Praecox) 01/2020 - 06/2002
22	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 04/2004
20	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 03/2002
16	Anxiety Disorders (Anxiety Disorder) 03/2024 - 01/2002
13	Depressive Disorder (Melancholia) 10/2023 - 01/2002
11	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 04/2004
11	Bipolar Disorder (Manic Depressive Psychosis) 06/2012 - 01/2003
7	Cognitive Dysfunction 07/2017 - 10/2007
6	Mood Disorders (Mood Disorder) 07/2015 - 07/2002
6	Dementia (Dementias) 02/2015 - 02/2002
6	Mania (Manias) 08/2013 - 06/2002
6	Weight Gain 03/2009 - 05/2006
5	Mental Disorders (Mental Disorder) 04/2015 - 01/2007
4	Personality Disorders (Personality Disorder) 01/2022 - 01/2007
4	Borderline Personality Disorder (Personality Disorders, Borderline) 07/2008 - 04/2007
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 02/2008
3	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2008
3	Psychomotor Agitation (Akathisia) 07/2019 - 12/2010
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2015 - 03/2013
3	Disease Progression 02/2015 - 10/2002
3	Atrophy 09/2011 - 05/2005
3	Panic Disorder (Panic Attack) 04/2007 - 10/2002
3	Sleep Deprivation 01/2006 - 01/2002
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 10/2004 - 10/2002
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023 - 01/2008
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 06/2010
2	Treatment-Resistant Schizophrenia 03/2017 - 07/2012
2	Prodromal Symptoms 03/2016 - 04/2004
2	Treatment-Resistant Depressive Disorder 09/2013 - 01/2006
2	Neuralgia (Stump Neuralgia) 04/2008 - 03/2006
2	Pain (Aches) 04/2008 - 03/2006
2	Down Syndrome (Down's Syndrome) 04/2004 - 10/2003
2	Somatoform Disorders (Somatoform Disorder) 08/2003 - 11/2002
1	Eructation (Eructations) 04/2024
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Neurobehavioral Manifestations 07/2017

Drug/Important Bio-Agent (IBA)

51	Antipsychotic Agents (Antipsychotics)IBA 07/2019 - 06/2002
28	Antidepressive Agents (Antidepressants)IBA 01/2018 - 01/2002
14	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2014 - 06/2002
11	lavender oilIBA 04/2024 - 09/2010
11	Haloperidol (Haldol)FDA LinkGeneric 07/2019 - 04/2004
10	Biomarkers (Surrogate Marker)IBA 01/2016 - 02/2002
9	Quetiapine Fumarate (Seroquel)FDA Link 06/2012 - 12/2005
8	Anti-Anxiety Agents (Anxiolytics)IBA 04/2024 - 01/2003
6	LithiumIBA 06/2012 - 06/2003
5	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2023 - 10/2002
5	BenzodiazepinesIBA 01/2022 - 01/2002
5	Amyloid (Amyloid Fibrils)IBA 03/2015 - 10/2003
5	Proteins (Proteins, Gene)FDA Link 06/2014 - 07/2003
5	tau Proteins (tau Protein)IBA 06/2009 - 08/2002
4	Cholinergic Agents (Cholinergics)IBA 03/2016 - 11/2005
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2015 - 01/2003
4	Serotonin (5 Hydroxytryptamine)IBA 06/2012 - 10/2004
4	Amisulpride (Solian)IBA 08/2010 - 10/2003
4	Threonine (L-Threonine)FDA Link 01/2006 - 08/2002
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2023 - 10/2002
3	Psychotropic Drugs (Psychoactive Drugs)IBA 12/2016 - 08/2003
3	N-Methylaspartate (NMDA)IBA 01/2013 - 04/2006
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2013 - 04/2006
3	Valproic Acid (Depakote)FDA LinkGeneric 06/2012 - 07/2007
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2012 - 02/2008
3	A-factor (Streptomyces)IBA 04/2012 - 06/2002
3	Olanzapine (Zyprexa)FDA Link 03/2012 - 10/2007
3	Transcription Factor 4IBA 05/2011 - 08/2009
3	Mirtazapine (Rexer)FDA LinkGeneric 04/2011 - 03/2003
3	Celecoxib (Celebrex)FDA Link 08/2010 - 06/2002
3	gamma-Aminobutyric Acid (GABA)IBA 02/2010 - 01/2003
2	ziprasidone (Geodon)FDA Link 07/2019 - 07/2019
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2018 - 01/2006
2	Galantamine (Galanthamine)FDA LinkGeneric 11/2015 - 04/2009
2	Methylphenidate (Ritalin)FDA LinkGeneric 11/2014 - 03/2013
2	EsketamineIBA 09/2013 - 01/2009
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2013 - 10/2004
2	Dopamine (Intropin)FDA LinkGeneric 03/2013 - 11/2012
2	AntibodiesIBA 07/2012 - 08/2002
2	Lamotrigine (Lamictal)FDA LinkGeneric 06/2012 - 03/2012
2	aminotris(methylenephosphonato)diamminoplatinum (II) (AMDP)IBA 02/2011 - 04/2009
2	Therapeutic UsesIBA 08/2010 - 06/2009
2	amyloid beta-protein (1-42)IBA 06/2009 - 08/2002
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2008 - 03/2006
2	Donepezil (Aricept)FDA LinkGeneric 07/2006 - 04/2003
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2005 - 02/2003
2	Amyloid beta-PeptidesIBA 04/2005 - 08/2002
2	Interleukin-6 (Interleukin 6)IBA 02/2004 - 02/2003
2	Amino Acids FDA Link 07/2003 - 08/2002
2	CytokinesIBA 02/2003 - 06/2002
1	Volatile Oils (Essential Oils)IBA 03/2024
1	factor AIBA 01/2023
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2023
1	ParvalbuminsIBA 01/2020
1	Rivastigmine (Exelon)FDA LinkGeneric 03/2016
1	Memantine (Namenda)FDA Link 11/2015

Therapy/Procedure

19	Therapeutics 01/2023 - 03/2002
8	Drug Therapy (Chemotherapy) 06/2012 - 01/2003
4	Injections 09/2010 - 05/2005
4	Aftercare (After-Treatment) 04/2009 - 11/2003
3	Secondary Prevention 02/2011 - 04/2004
2	Patient Readmission 01/2016 - 09/2005
2	Transcranial Magnetic Stimulation 04/2007 - 05/2002
1	Drug Prescriptions 01/2018